Lataa...
Lurasidone Ingestions Reported to Texas Poison Centers
Background: Lurasidone is an atypical antipsychotic approved for the treatment of schizophrenia in 2010. There is limited information on potentially toxic events involving lurasidone outside of clinical investigations. Objective: This investigation describes potentially toxic lurasidone ingestions f...
Tallennettuna:
| Julkaisussa: | J Pharm Technol |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
SAGE Publications
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990146/ https://ncbi.nlm.nih.gov/pubmed/34860899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122514533305 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|